Researchers at Ohio State University Publish New Data on Rheumatoid Arthritis (Inhibition of BET Proteins Regulates Fcg Receptor Function and Reduces Inflammation in Rheumatoid Arthritis).
In: Drug Week, 2023-05-19, S. 1744-1744
serialPeriodical
Zugriff:
Keywords: Arthritis; Autoimmune Diseases and Conditions; Drugs and Therapies; Health and Medicine; Inflammation; Joint Diseases and Conditions; Musculoskeletal Diseases and Conditions; Pharmaceuticals; Rheumatoid Arthritis EN Arthritis Autoimmune Diseases and Conditions Drugs and Therapies Health and Medicine Inflammation Joint Diseases and Conditions Musculoskeletal Diseases and Conditions Pharmaceuticals Rheumatoid Arthritis 1744 1744 1 05/15/23 20230519 NES 230519 2023 MAY 19 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Data detailed on rheumatoid arthritis have been presented. Bromodomain and extra-terminal protein (BET) inhibition is associated with reduced immune responses, making the BET family a potential therapeutic target for autoimmune diseases such as rheumatoid arthritis (RA). [Extracted from the article]
Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Researchers at Ohio State University Publish New Data on Rheumatoid Arthritis (Inhibition of BET Proteins Regulates Fcg Receptor Function and Reduces Inflammation in Rheumatoid Arthritis).
|
---|---|
Zeitschrift: | Drug Week, 2023-05-19, S. 1744-1744 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1531-6440 (print) |
Sonstiges: |
|